The Latest
-
Why this HALO focused ASX ETF outperformed over the last month
-
Telix Pharmaceuticals announces US$40m Regeneron radiopharma deal
-
Brambles shares: Class action judgment update
-
Missed BHP shares’ massive run? Here’s what could happen next